【摘要】 目的 探讨中药汤剂银翘散加味联合醋酸泼尼松、盐酸倍他司汀治疗急性前庭神经炎(AVN)的临床效果。方法 选取2023年6月—2025年5月北京市怀柔区中医医院收治的64例AVN患者，按随机数字表法分为观察组与对照组，各32例。对照组采用醋酸泼尼松、盐酸倍他司汀联合治疗，观察组在对照组的基础上加用中药汤剂银翘散加味。比较两组的临床疗效、眩晕情况、前庭症状、前庭功能、炎症因子水平和不良反应。结果 治疗2周后，观察组临床总有效率高于对照组，眩晕残障评定量表评分、前庭症状指数评分、半规管轻瘫值、白细胞计数、中性粒细胞计数均低于对照组(P<0.05)。两组不良反应总发生率比较，差异无统计学意义(P>0.05)。结论 银翘散加味联合醋酸泼尼松、盐酸倍他司汀治疗AVN患者的临床效果显著，可改善患者的前庭功能，减轻其眩晕症状与炎症反应，且不会增加不良反应。更多还原

【Abstract】 Objective To investigate the clinical effect of modified Yinqiao Powder combined with Prednisone Acetate and Betahistine Hydrochloride in the treatment of acute vestibular neuritis(AVN). Methods A total of 64 patients with AVN admitted to Beijing Huairou Hospital of Traditional Chinese Medicine from June 2023 to May 2025 were selected and divided into observation group and control group according to the random number table method, 32 cases in each group. The control group was treated with Prednisone Acetate and Betahistine Hydrochloride, and the observation group was treated with modified Yinqiao Powder on the basis of the control group. The clinical efficacy, vertigo, vestibular symptoms, vestibular function, inflammatory factor levels and adverse reactions were compared between the two groups. Results After 2 weeks of treatment, the total clinical effective rate of the observation group was higher than that of the control group, and the Dizziness Handicap Inventory score, Vestibular Symptom Index score, canal paresis value, white blood cell count and neutrophil count were lower than those of the control group(P < 0.05). There was no significant difference in the total incidence of adverse reactions between the two groups(P > 0.05). Conclusions The clinical effect of modified Yinqiao Powder combined with Prednisone Acetate and Betahistine Hydrochloride in the treatment of AVN patients is significant, which can improve the vestibular function of patients, reduce their vertigo symptoms and inflammatory reactions, and will not increase adverse reactions.更多还原